Diagnosis of cutaneous lymphoma, clinical features, and follow-up data in our group of patients
| Diagnosis . | No. of patients . | Sex (M:F) . | Median age, y (range) . | Median follow-up, mo (range) . | Estimated 5-y survival, % . |
|---|---|---|---|---|---|
| T-cell lymphomas | |||||
| Mycosis fungoides | 281 | 2.02 :1 | 61 (9-88) | 38 (6-605) | 89 |
| Mycosis fungoides-associated follicular mucinosis | 25 | 4 :1 | 51 (33-74) | 51 (6-262) | 93 |
| Pagetoid reticulosis | 1 | 1 :0 | 68 | 60 | 100 |
| Lymphomatoid papulosis | 43 | 1.38 :1 | 47 (4-86) | 48 (6-366) | 100 |
| CD 30+ cutaneous large T-cell lymphoma | 18 | 3.5 :1 | 57 (3-70) | 30 (6-201) | 100 |
| Sezary syndrome | 22 | 4.5 :1 | 66.5 (32-91) | 28 (7-115) | 33 |
| CD30− cutaneous large T-cell lymphoma | 2 | 1 :1 | 55 (34-76) | 9 (7-11) | 100 |
| Pleomorphic small/medium-sized cutaneous T-cell lymphoma | 7 | 0.75 :1 | 65 (53-80) | 41 (7-227) | 80 |
| Primary cutaneous NK cell lymphoma | 3 | 2 :1 | 63 (31-66) | 31 (30-50) | 0 |
| Primary cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma | 4 | 3 :1 | 61.5 (48-65) | 30.5 (7-36) | 0 |
| Subcutaneous panniculitislike T-cell lymphoma | 3 | 0.5 :1 | 39 (29-48) | 54 (44-75) | 100 |
| B-cell lymphomas | |||||
| Primary cutaneous follicle center cell lymphoma | 60 | 0.76 :1 | 58.5 (20-89) | 41.5 (6-313) | 94 |
| Primary cutaneous immunocytoma/marginal zone B-cell lymphoma | 62 | 1.69 :1 | 55.5 (17-86) | 48 (7-292) | 98 |
| Large B-cell lymphoma of the leg | 23 | 0.76 :1 | 72 (43-86) | 13 (8-168) | 58 |
| Plasmacytoma | 2 | 2 :0 | 52.5 (50-55) | 21 (12-30) | 100 |
| Diagnosis . | No. of patients . | Sex (M:F) . | Median age, y (range) . | Median follow-up, mo (range) . | Estimated 5-y survival, % . |
|---|---|---|---|---|---|
| T-cell lymphomas | |||||
| Mycosis fungoides | 281 | 2.02 :1 | 61 (9-88) | 38 (6-605) | 89 |
| Mycosis fungoides-associated follicular mucinosis | 25 | 4 :1 | 51 (33-74) | 51 (6-262) | 93 |
| Pagetoid reticulosis | 1 | 1 :0 | 68 | 60 | 100 |
| Lymphomatoid papulosis | 43 | 1.38 :1 | 47 (4-86) | 48 (6-366) | 100 |
| CD 30+ cutaneous large T-cell lymphoma | 18 | 3.5 :1 | 57 (3-70) | 30 (6-201) | 100 |
| Sezary syndrome | 22 | 4.5 :1 | 66.5 (32-91) | 28 (7-115) | 33 |
| CD30− cutaneous large T-cell lymphoma | 2 | 1 :1 | 55 (34-76) | 9 (7-11) | 100 |
| Pleomorphic small/medium-sized cutaneous T-cell lymphoma | 7 | 0.75 :1 | 65 (53-80) | 41 (7-227) | 80 |
| Primary cutaneous NK cell lymphoma | 3 | 2 :1 | 63 (31-66) | 31 (30-50) | 0 |
| Primary cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma | 4 | 3 :1 | 61.5 (48-65) | 30.5 (7-36) | 0 |
| Subcutaneous panniculitislike T-cell lymphoma | 3 | 0.5 :1 | 39 (29-48) | 54 (44-75) | 100 |
| B-cell lymphomas | |||||
| Primary cutaneous follicle center cell lymphoma | 60 | 0.76 :1 | 58.5 (20-89) | 41.5 (6-313) | 94 |
| Primary cutaneous immunocytoma/marginal zone B-cell lymphoma | 62 | 1.69 :1 | 55.5 (17-86) | 48 (7-292) | 98 |
| Large B-cell lymphoma of the leg | 23 | 0.76 :1 | 72 (43-86) | 13 (8-168) | 58 |
| Plasmacytoma | 2 | 2 :0 | 52.5 (50-55) | 21 (12-30) | 100 |